Clinical Trials Logo

Shock clinical trials

View clinical trials related to Shock.

Filter by:

NCT ID: NCT04114162 Recruiting - Shock, Septic Clinical Trials

Fluid Overload Quantification in Septic Shock

FOTOShock
Start date: January 1, 2020
Phase:
Study type: Observational

Fluid management in septic shock patients remain a great challenge. Insufficient fluid filling lead to hypovolemia, organ failure and increased death, whereas fluid overload was associated to an increased morbidity and mortality in several studies. Several invasive and non invasive strategies have been developed during the past years to monitor the hemodynamic state of septic shock patients, but no method has been validated to objectively quantify fluid overload in septic shock patients. The Body Composition Monitor (BCM) allow for measurement of total body water (TBW), extracellular water (ECW) and intracellular water (ICW) volumes using bioimpedancemetry. The BCW is daily used in patients who undergo renal dialysis to assess the effectiveness of fluid removal. The BCM has never been validated in septic shock patients. The aim of the study is to investigate the accuracy of the BCM to measure the variation of the TBW during a fluid challenge of 500 ml of saline during the early phase of septic shock.

NCT ID: NCT04111822 Completed - Sepsis Clinical Trials

Pilot Study on the Use of Hydrocortisone, Vitamin c and Tiamine in Patient With Sepsis and Septic Shock

Start date: October 31, 2018
Phase: Phase 3
Study type: Interventional

Due to the high incidence, mortality and short and long term complications of sepsis and septic shock, it is necessary to look for strategies to try to minimize this impact.

NCT ID: NCT04110418 Recruiting - Neonatal Sepsis Clinical Trials

Methylene Blue Versus Vasopressin Analogue for Treatment of Septic Shock in Preterm Neonate

Start date: February 19, 2019
Phase: Phase 2
Study type: Interventional

A randomized, prospective study comparing methylene blue versus terlipressin in treatment of catecholamines resistant shock in preterm neonate

NCT ID: NCT04107402 Active, not recruiting - Covid19 Clinical Trials

PLatelets Acetyl-CoA Carboxylase Phosphorylation State in SEPtic Shock

PLACCSEPS
Start date: March 15, 2019
Phase: N/A
Study type: Interventional

Knowing the dramatic increase in thrombin generation during sepsis, our research hypothesis is that AMPK-induced ACC phosphorylation in platelets is increased and that this might modulate platelets metabolism and more particularly platelets inflammatory mediators content, coming from AA and lipids.

NCT ID: NCT04102371 Recruiting - Shock Clinical Trials

Pragmatic Pediatric Trial of Balanced Versus Normal Saline Fluid in Sepsis

PRoMPT BOLUS
Start date: August 25, 2020
Phase: Phase 3
Study type: Interventional

The objectives of this multicenter pragmatic clinical trial are to compare the effectiveness and relative safety of balanced fluid resuscitation versus 0.9% "normal" saline in children with septic shock, including whether balanced fluid resuscitation can reduce progression of kidney injury.

NCT ID: NCT04092036 Not yet recruiting - Shock Clinical Trials

Optic Nerve Sheath Diameter in Prediction of Fluid Responsiveness

Start date: October 15, 2019
Phase:
Study type: Observational [Patient Registry]

The aim of the study to examine Optic Nerve Sheath Diameter measurement for prediction of fluid responsiveness in hemodynamically unstable patients

NCT ID: NCT04089098 Completed - Septic Shock Clinical Trials

VOLume and Vasopressor Therapy in Patients With Hemodynamic instAbility

VOLTA
Start date: September 1, 2019
Phase:
Study type: Observational

This prospective observational study will include critically ill patients with hemodynamic compromise. It will compare passive leg raising and a mini volume challenge (MVC) carried out on every patient sequentially. The endogenous release of stress hormones will also be assayed in order to investigate their modifying effect on the hemodynamic reaction of the participants. The effect of fluid resuscitation on renal perfusion will also be assessed and the data compared with the release of cystatin C.

NCT ID: NCT04089072 Recruiting - Septic Shock Clinical Trials

Methylene Blue as a Third-line Vasopressor in Septic Shock

Start date: December 1, 2019
Phase: Phase 2
Study type: Interventional

A randomized, prospective study comparing ProvayBlue® to standard care with multiple sympathomimetic vasopressors.

NCT ID: NCT04080453 Completed - Septic Shock Clinical Trials

Pro-inflammatory Role of Blood Platelets in Critically Ill Patients With Septic Shock.

PLAQSIS
Start date: November 9, 2020
Phase:
Study type: Observational

Blood platelets play a major role in the inflammatory response. A dysregulation of platelets activation may be one of the contributors to tissue damage in critically ill patients with septic shock. The main objective of this study is to compare platelet activation markers levels (including plasma concentration in CD154, beta thromboglobulin, platelet factor 4, platelet microparticles, soluble CD62, RANTES, GRO-alpha and HMGB-1) at the early phase of a septic shock and a systemic inflammatory response syndrome (SIRS).

NCT ID: NCT04079829 Active, not recruiting - Respiratory Failure Clinical Trials

Postoperative Respiratory Abnormalities

AI-ARF
Start date: September 1, 2019
Phase:
Study type: Observational

The study aims to determine how historical cases of respiratory abnormalities are documented by clinicians in the electronic health records (EHR) of Memorial Hermann Healthcare System (MHHS) inpatient facilities. The knowledge gained from this study will support the design of modern data-driven surveillance approach to continuously collect, monitor and timely recognize postoperative respiratory abnormalities using electronic healthcare recorded data.